Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

Hybrigenics Services


Genopole Campus 3 – 1 rue Pierre Fontaine – Bâtiment 1
91000 EVRY Courcouronnes – FRANCE
Phone: +33 (0)1 75 66 20 54
Email: jcrain@hybrigenics.com

CEO: Jean-Christophe RAIN
Director of Chemistry: Marie-Edith Gourdel
Web Site >
Hybrigenics - Genopole's company Hybrigenics - Genopole's company

#R&D Services and Products #Biomanufacturing / Pharmaceutical Services

  • Protein interactions
  • Drug target deconvolution
  • Molecular glues
  • Nanobodies

Field of Activity


Hybrigenics Services proposes fee-for-services R&D support. It provides innovative technological platforms for
i) protein interaction studies (protein-protein, drug-protein, mechanisms of action) and
ii) selection and validation of VHH antibodies.

BACKGROUND
Launched in 1998 as Hybrigenics SA, a first spin-off from Institut Pasteur Paris, the company optimizes a yeast two-hybrid system for protein-protein interaction discovery. Its services activities were launched in 2003. Hybrigenics Services has developed new versions for drug discovery (2013, mechanism of action; 2019 molecular glues/PROTACs). A novel nanobody selection platform was launched in 2016.
The company is an independent entity since 2017.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Hybrigenics Services has technological platforms for the:

  • discovery of novel protein-protein interactions, Protein network (ULTImate Y2H™)
  • identification of small molecule interactions, e.g., proteins, their therapeutic targets, elucidation of mechanisms of action for drug candidates (ULTImate YChemH™)
  • identification of PPIs induced by small molecules (molecular glues, PROTACs, etc.) for targeted protein degradation (TPD) & stabilization projects (ULTImate Y2HChem™)
  • selection and validation of VHH antibodies (HYBRIBODY™)

CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS

  • The company counts 3,000 clients and partners across the globe and the spectrum of scientific domains (pharma, agriculture, cosmetics, basic research). Biotechs from start-ups to large corporations in pharma and agriculture, academic research.
  • Hybrigenics Services has established scientific and technological renown with more than 500 publications on its results in top-ranked journals
  • Hybrigenics Services completes more than 150 mostly confidential service contracts yearly, with pricings ranging from several thousand to several hundred thousand euros

PARTNERSHIPS SOUGHT
Hybrigenics Services seeks partnerships with biotechs, start-ups, the pharmaceutical industry, and actors in agricultural sciences and academic research.

  • Further Information

    2 Patents
    30 Staff Members
    Strengths:

    • Field-leading Y2H screening platform with a very large collection (130) of cDNA libraries (45 species: human, animals, plants, model organisms, bacteria, etc.), exhaustive screening and integrated bioinformatics.
    • Nanobodies: Animal-free technique to select synthetic VHH antibodies from a patented bank of 3X10⁹ humanized camalid VHHs.
    • 25 years of experience
    • 10,000 Y2H and associated screenings

    Innovation Assets:
    Continuously listening to the needs of researchers to bring them new, pertinent solutions.
    Other facts:
    Hybrigenics Services is a private, management/employee-owned company. It practices corporate social responsibility. Hybrigenics Services measured its carbon footprint in 2021 and deployed specific actions to reduce its environmental impact.

Share
Genopole’s Companies

#R&D Services and Products


In same field

Quibiotic - Projet Shaker

Quibiotic

Quibiotic develops three molecular synthesis platforms aimed at innovatively modifying β-lactam rings for new anti-infectives.

Discover
Adlin Science - Genopole's Company

Adlin Science

ADLIN Science accompanies researchers in the management, analysis and valorization of multiomic data

Discover
Altar - entreprise génopolitaine

Altar

Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover
Yubsis - Genopole's company

Yubsis

Yubsis provides Biological Science Information Solutions. Our platform is designed for research organizations (Pharma, Biotech, academic lab) willing to improve real-time teamwork, optimize performance and accelerate innovation.

Discover
Xentech - Genopole Company

XenTech

XenTech is an innovative biotech company specialized in the preclinical evaluation of cancer drugs and the identification of biomarkers and therapeutic targets.

Discover
Whitelab Genomics - Genopole's Company

WhiteLab Genomics

Artificial intelligence to optimize and accelerate the development of gene therapies

Discover
Pymabs - Genopole's Company

Pymabs

R & D services in the field of transient expression of recombinant proteins in plants.

Discover
Polytheragene - Genopole's Company

Polytheragene

Manufacture and sale of new high performance transfecting agents for gene therapy, high-throughput screening and biomanufacturing. Cosmetic and therapeutic molecules from plant biomass.

Discover
Phinc Development - Genopole's Company

PhinC Development

PhinC Development brings its expertise to small and mid-sized biotechs and pharmaceutical companies looking to advance their early-stage drug research.

Discover
New England Biolabs - Genopole's Company

New England Biolabs France

New England Biolabs is a private company manufacturing reagents for the life science industry particularly focused on products for genomic research.

Discover
LPS Biosciences - Genopole's company

LPS-BioSciences

LPS-BioSciences is specialized in bacterial endotoxins. It combines an exclusive proprietary technology for endotoxin production and characterization. and its acquired experience in the fields of vaccines, diagnostics, and the food industry.

Discover
logo abcell Bio - Genopole's Companie

ABCell-Bio

Abcell-bio is a laboratory specializing in the isolation of human hematopoietic stem cells and primary cells derived from perinatal tissue and cord blood.

Discover
View all >
With the support from